“…Most of these efforts are focused on donor cells. These include: (a) synchrony of the cell cycle stage of donor cells (Kasinathan et al, 2001;Gibbons et al, 2002;Wells et al, 2003), as well as synchrony between donor cells and recipient oocytes (Campbell et al, 1994;Du et al, 2002); (b) using somatic cells from donors of various ages (Renard, 1999;Hill et al, 2000;Tian et al, 2000;Kasinathan et al, 2001;Xue et al, 2002), tissue origins (Galli et al, 1999;Shiga et al, 1999;Kato et al, 2000;Ogura et al, 2000;Du et al, 2002;Hochedlinger and Jaenisch, 2002;Miyashita et al, 2002), passages (Shiga et al, 1999;Arat et al, 2001;Liu et al, 2001) and culture conditions (Zakhartchenko et al, 1999b); (c) transfer of stem cells with low levels of epigenetic marks (Kato et al, 1999a;Wakayama et al, 1999;Amano et al, 2001;Eggan et al, 2001;Humpherys et al, 2001;Zhou et al, 2001); and (d) modifying epigenetic marks of donor cells with drugs (Jones et al, 2001;Zhou et al, 2002;Enright et al, 2003). Wilmut et al (2002) reported that a number of cellular factors influence the outcome of cloned offspring.…”